DekaBank Deutsche Girozentrale - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$13,515,000
+683.0%
292,400
+162.0%
0.07%
+580.0%
Q1 2019$1,726,000
-23.5%
111,600
-28.6%
0.01%
-33.3%
Q4 2018$2,256,000
+30.7%
156,200
+40.0%
0.02%
+50.0%
Q3 2018$1,726,000
-10.8%
111,600
-2.5%
0.01%
-23.1%
Q2 2018$1,935,000
-37.4%
114,500
-39.7%
0.01%
-38.1%
Q1 2018$3,093,000
+263.9%
190,000
+100.8%
0.02%
+200.0%
Q4 2017$850,0000.0%94,6000.0%0.01%0.0%
Q3 2017$850,000
+6.4%
94,6000.0%0.01%
+16.7%
Q2 2017$799,000
-7.0%
94,6000.0%0.01%
-25.0%
Q1 2017$859,000
+41.7%
94,600
+35.1%
0.01%
+33.3%
Q4 2016$606,000
+206.1%
70,000
+2.9%
0.01%
+200.0%
Q1 2016$198,000
-34.0%
68,000
-6.1%
0.00%
-33.3%
Q4 2015$300,000
-7.1%
72,400
+2.1%
0.00%
-25.0%
Q3 2015$323,000
-34.1%
70,900
+4.4%
0.00%
-33.3%
Q2 2015$490,000
+1.7%
67,900
+3.8%
0.01%0.0%
Q1 2015$482,000
+42.6%
65,400
-7.8%
0.01%
+50.0%
Q4 2014$338,000
+22.5%
70,900
-8.4%
0.00%0.0%
Q3 2014$276,000
-16.4%
77,400
+6.9%
0.00%
-20.0%
Q2 2014$330,000
-8.1%
72,400
-5.2%
0.01%
-16.7%
Q1 2014$359,000
+10.1%
76,400
+14.2%
0.01%
+20.0%
Q4 2013$326,000
-19.9%
66,900
+2.3%
0.01%
-28.6%
Q3 2013$407,00065,4000.01%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 16,618,776$146,079,00012.59%
BVF INC/IL 4,986,186$43,829,0008.81%
First Light Asset Management, LLC 1,000,361$8,793,0003.86%
Crosspoint Capital Strategies, LLC 463,005$4,070,0003.62%
Consonance Capital Management LP 2,723,471$23,912,0002.63%
KOPP INVESTMENT ADVISORS LLC 219,926$1,933,0002.04%
SPHERA FUNDS MANAGEMENT LTD. 900,000$7,911,0002.00%
Orbimed Advisors 16,088,800$141,421,0001.80%
Cormorant Asset Management, LP 1,150,000$10,109,0001.36%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 2,073,680$18,227,0001.26%
View complete list of ARRAY BIOPHARMA INC shareholders